Your firm released drug product in which the strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.
Inspection Record
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy — FDA 483 Findings
Inspectors Bei Y HeThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Visual inspection of finished drug products prior to distribution is not adequately performed.
Non-sterile, low-shedding wipes are used to cleaned the ISO 5 hoods.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.